The nanoparticles demonstrate the ability to effectively suppress both osteoclast differentiation and tumor cell growth by inhibiting the NF‐κB signaling pathway, thereby disrupting the vicious cycle in the osteosarcoma microenvironment. The gene discussed is NFKB1; the disease is osteosarcoma.